Background and Purpose: Intracranial hemorrhage (ICH) constitutes an important subtype of stroke. In a prior study, we found that the city of Changsha, People’s Republic of China, not only had a high incidence of stroke, but also had almost the highest incidence of cerebral hemorrhage. To provide information for preventing and managing ICH, we undertook this study supervising and determining the annual first-ever average incidence of cerebral hemorrhage from 1986 to 2000 in Changsha. Methods: In January 1986, people from 6 well-defined communes in the Kai-fu district in Changsha were selected as the study population. Since 1991, we added another 18 well-defined communes of the same district. Data on these residents were obtained from the census register of the local administrative office. Persons who had a history of stroke were excluded from our study at the beginning. Every year, we checked up on the population and carried out door-to-door inquiries to verify the new cases of ICH and stroke. If the patients were diagnosed in hospital, as many as possible were examined with CT and/or MRI. The incidence rate adjusted to the World population in 1985 for age and sex, as well as the prevalence of risk factors were calculated. Results: An accumulative total of 551,163 people were supervised in 15 years (from 1986 to 2000); the annual average incidences of stroke and ICH were 236.6/100,000 (adjusted rate: 154.7) and 131.0/100,000 (adjusted rate: 73.1), respectively. From 1986 to 2000, the total annual average rate of stroke confirmed by CT and/or MRI in Changsha was 70.8%, and for ICH it was 64.7%. The incidences of stroke and ICH confirmed by image analysis were 167.5 (adjusted rate: 110.8) and 84.7 (adjusted rate: 55.1), respectively. The mean annual mortality rate of ICH was 78.3/100,000 (adjusted rate: 49.3) and that of stroke was 124.5/100,000 (adjusted rate: 97.0). The percentage of ICH among stroke cases was 55.4%. Among patients with ICH, 79.8% had hypertension, 30.6% had cardiovascular disease, 7.6% had diabetes mellitus, and 12.5% had an abnormal high level of lipid. Among patients with other subtypes of stroke apart from ICH, the percentages were 76.6, 40.6, 15.5, and 22.5%. Conclusions: The incidence of ICH in Changsha is very high, so is the proportion of ICH among all stroke cases. Changsha is an area with a high incidence of ICH in the world. Hypertension is the prominent risk factor. The study demonstrated the importance of ICH as a significant subtype of stroke.

1.
Jacobs BS, Boden-Albala B, Lin IF, Sacco RL: Stroke in the young in the northern Manhattan stroke study. Stroke 2002;33:2789–2793.
2.
Hajat C, Dundas R, Stewart JA, Lawrence E, Rudd AG, Howard R, Wolfe CD: Cerebrovascular risk factors and stroke subtypes: Differences between ethnic groups. Stroke 2001;32:37–42.
3.
Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM, Mensah GA: Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. Stroke 2002;33:1197–1201.
4.
He J, Micheal JK, Wu Z, Whelton PK: Stroke in the People’s Repulic of China. 1. Geographic variations in incidence and risk factors. Stroke 1995;26:2222–2227.
5.
Fang XH, Kronmal RA, Li SC, Longstreth WT Jr, Cheng XM, Wang WZ, Wu S, Du XL, Siscovick D: Prevention of stroke in urban China. A community-based intervention trial. Stroke 1999;30:495–501.
6.
Wu YK: Epidemiology and community control of hypertension, stroke and coronary heart disease in China. Chin Med J (Engl) 1979;92:665–670.
7.
Bonita R, Stewart A, Beaglehole R: International trends in stroke mortality: 1970–1985. Stroke 1990;21:989–992.
8.
Sudlow CL, Warlow CP: Comparing stroke incidence worldwide: What makes studies comparable? Stroke 1996;27:550–558.
9.
Lauria G, Gentile M, Fassetta G, Casetta I, Agnoli F, Andreotta G, Barp C, Caneve G, Cavallaro A, Cielo R, et al: Incidence and prognosis of stroke in the Belluno province, Italy. First-year results of a community-based study. Stroke 1995;26:1787–1793.
10.
Nilsson OG, Lindgren A, Stahl N, Brandt L, Saveland H: Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 2000;69:601–607.
11.
Thrift AG, Dewey HM, Macdonell RA, McNeil JJ, Donnan GA: Incidence of the major stroke subtypes: Initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke 2001;32:1732–1738.
12.
Reunanen A, Aho K, Aromaa A, Knekt P: Incidence of stroke in a Finnish prospective population study. Stroke 1986;17:675–681.
13.
Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H: A 15.5-year follow-up study in a Japanese provincial city. The Shibata Study. Stroke 1997;28:45–52.
14.
Giroud M, Milan C, Beuriat P, Gras P, Essayagh E, Arveux P, Dumas R: Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortival infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985–1989. Int J Epidemiol 1991;20:892–899.
15.
Broderick JP, Brott T, Tomsick T, Miller R, Huster G: Intracerebral hemorrhage more than twice as common as subarachniod hemorrhage. J Neurosurg 1993;78:188–191.
16.
Caicoya M, Rodriguez T, Lasheras C, Cuello R, Corralee C, Blazquez B: Stroke incidence in Asturias, 1990–1991. Rev Neurol 1996;24:806–811.
17.
Cabral NL, Longo AL, Moro CH, Amaral CH, Kiss HC: Epidemiology of cerebrovascular disease in Joinville, Brazil. An Institutional Study. Arq Neuropsiquiatr 1997;55:357–363.
18.
Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al: A Prospective Community-Based Study of Stroke in Germany – The Erlangen Stroke Project (ESPro) incidence and case fatality at 1, 3, and 12 months. Stroke 1998;29:2501–2506.
19.
Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T, et al: A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981–1986. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988;51:1373–1380.
20.
Jerntorp P, Berglund G: Stroke registry in Malmö, Sweden. Stroke 1992;23:357–361.
21.
Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA: Stroke incidence among white, black, and Hispanic residents of an urban community: The Northern Manhattan Stroke Study. Am J Epidemiol 1998;147:259–268.
22.
Saposnik G, Gonzalez L, Lepera S, et al: Southern Buenos Aires stroke project. Acta Neurol Scand 2001;104:130–135.
23.
Shi F, Hart RG, Sherman DG, Tegeler CH: Stroke in the People’s Republic of China. Stroke 1989;20:1581–1585.
24.
Giroud M, Beuriat P, Vion P, D’Athis PH, Dusserre L, Dumas R: Stroke in a French prospective population study. Neuroepidemiology 1989;8:97–104.
25.
D’Alessandro G, Di Giovanni M, Roveyaz L, Iannizzi L, Compagnoni MP, Blanc S, Bottacchi E: Incidence and prognosis of stroke in the Valle d’Aosta, Italy. First-year results of a community-based study. Stroke 1992;23:1712–1715.
26.
Banerjee TK, Mukherjee CS, Sarkhel A: Stroke in the urban population of Calcutta – An epidemiological study. Neuroepidemiology 2001;20:201–207.
27.
Vemmos KN, Bots ML, Tsibouris PK, Zis VP, Grobbee DE, Stranjalis GS, Stamatelopoulos S: Stroke incidence and case fatality in southern Greece: The Arcadia stroke registry. Stroke 1999;30:363–370.
28.
Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM, Mensah GA: Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. Stroke 2002;33:1197–1201.
29.
Ayala C, Greenlund KJ, Croft JB, Keenan NL, Donehoo RS, Giles WH, Kittner SJ, Marks JS: Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995–1998. Am J Epidemiol 2001;154:1057–1063.
30.
Vemmos KN, Takis CE, Georgilis K, Zakopoulos NA, Lekakis JP, Papamichael CM, Zis VP, Stamatelopoulos S: The Athens stroke registry: Results of a five-year hospital-based study. Cerebrovasc Dis 2000;10:133–141.
31.
Immonen-Raiha P, Mahonen M, Tuomilehto J, Salomaa V, Kaarsalo E, Narva EV, Salmi K, Sarti C, Sivenius J, Alhainen K, Torppa J: Trends in case-fatality of stroke in Finland during 1983 to 1992. Stroke 1997;28:2493–2499.
32.
Thorvaldsen P, Kuulasmaa K, Rajakangas AM, Rastenyte D, Sarti C, Wilhelmsen L: Stroke trends in the WHO MONICA Project. Stroke 1997;28:500–506.
33.
Douglas J, Lanska, MD, Patrick M, Peterson, MS: Geographic variation in the decline of stroke mortality in the United States. Stroke 1995;26:1159–1165.
34.
Lawlor DA, Smith GD, Leon DA, Sterne JA, Ebrahim S: Secular trends in mortality by stroke subtype in the 20th century: A retrospective analysis. Lancet 2002;360:1818–1823.
35.
Dunbabin DW, Sandercock PA: Preventing stroke by the modification of risk factors. Stroke 1990;21(suppl 12):IV36–IV39.
36.
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765–774.
37.
Wong KS: Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: A prospective hospital-based study in Asia. Asian Acute Stroke Advisory Panel. Stroke 1999;30:2326–2330.
38.
Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP: Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study. Stroke 2002;33:1190–1195.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.